GenUltimate! TBG technology is designed to correct
Post# of 11802
(Total Views: 326)
Posted On: 04/04/2019 4:07:47 PM
Re: weaver_525 #6876
Quote:
GenUltimate! TBG technology is designed to correct for Hematocrit (HCT) interference inherent in all at-home testing methodologies. By accomplishing this correction, GenUltimate! TBG offers precision and accuracy wished for, but virtually unheard of in at-home testing of diabetics. In fact, in several of our recent verification testing, GenUltimate! TBG out-performed even the reference methodology. This is quite the accomplishment.
Setting its own standard, GenUltimate! TBG will be capable of reporting glucose results at a reproducible rate of +/- 8.0%, in an industry where +/- 15% is not only the norm but also the published FDA guidance specifications. The company plans patent applications as soon as a current round of financing is accomplished. The GenUltimate! TBG technology will also be used as an enhancement to our GenUltimate! and GenUltimate! 4Pets test strips, now in worldwide commercial use.
With this kind of accuracy the GenUltimate! TBG would definitely be a highly sought after product.
(1)
(0)Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼